✓ Enriched with full company details from live data.
IndustryBiotechnology Research
Employees11-50
HeadquartersBoston, Massachusetts, United States
Funding stageVenture (Round not Specified)
Total funding$36.6M
LinkedIn followers153
Est. revenue$3M
Orig3n received Emergency Use Authorization clearance for their COVID-19 test on April 10, 2020. In addition to continuing work to provide the world with more knowledge about themselves based on their DNA, Orig3n is providing much needed COVID-19 capacity
Technology stack
Click any tool to see other companies using it.
🔥 16 people from ORIG3N are searchable on evyAI — names, titles, and unlockable contact info.